Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07239102
What this trial is testing

Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis

Who this might be right for
EGFR Positive Non-small Cell Lung CancerCentral Nervous System MetastasisLeptomeningeal Metastasis
Beijing Tiantan Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01102231
What this trial is testing

Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage III Non-small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT05466149
What this trial is testing

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

Who this might be right for
NSCLC
Allist Pharmaceuticals, Inc. 100
Large-scale testing (Phase 3)Study completedNCT00820755
What this trial is testing

Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Merck KGaA, Darmstadt, Germany 583
Not applicableStudy completedNCT05070026
What this trial is testing

Comparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancersurgery on Perioperative Clinical Indexes、Inflammatory Reaction and Quality of Life Scores of Patients With Non-small Cell Lung Cancer

Who this might be right for
Video-assisted Thoracoscopic SurgeryInflammatory ReactionLife Scores
Shengjing Hospital 68
Testing effectiveness (Phase 2)UnknownNCT00801385
What this trial is testing

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Who this might be right for
Lung Cancer
Yonsei University 47
Testing effectiveness (Phase 2)Ended earlyNCT00526890
What this trial is testing

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT02831933
What this trial is testing

Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma

Who this might be right for
Lung Squamous Cell Carcinoma Stage IVNonsquamous Nonsmall Cell Neoplasm of LungMetastatic Uveal Melanoma
Eric Bernicker, MD 11
Testing effectiveness (Phase 2)Looking for participantsNCT06822543
What this trial is testing

A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Who this might be right for
Lung CancerNon Small Cell Lung CancerBrain Metastases
Latin American Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Study completedNCT03322540
What this trial is testing

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

Who this might be right for
Lung Cancer
Incyte Corporation 154
Early research (Phase 1)Study completedNCT04772989
What this trial is testing

Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more
Arcus Biosciences, Inc. 94
Early research (Phase 1)Study completedNCT03184168
What this trial is testing

Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers

Who this might be right for
Healthy Volunteers
Pfizer 6
Not applicableStudy completedNCT01537991
What this trial is testing

ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer
Lisette Nixon 81
Not applicableActive Not RecruitingNCT05863052
What this trial is testing

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Who this might be right for
Immune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more
University of Oklahoma 72
Testing effectiveness (Phase 2)WithdrawnNCT02672358
What this trial is testing

Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Testing effectiveness (Phase 2)UnknownNCT00052325
What this trial is testing

Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableNot Yet RecruitingNCT07310589
What this trial is testing

Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Taiwan University Hospital 178
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Testing effectiveness (Phase 2)Ended earlyNCT05219578
What this trial is testing

RTX-224 Monotherapy in Patients With Solid Tumors

Who this might be right for
Non Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more
Rubius Therapeutics 7
Next Page